HCV Nucleocapsid Core antigen, recombinant protein from E. coli
The E. coli derived recombinant protein contains the HCV core nucleoCapsid genotype 1b, immunodominant regions, amino acids 2-192, 22kDa. The protein is fused with b-galactosidase (114 kDa) at N-terminus.
HCV-Core protein was purified by proprietary chromatographic technique. HCV-Core Protein is > 95% pure as determined by 10% PAGE (coomassie staining).
2-8°C short term, -20°C long term
HCV is a small 50nm, enveloped, single-stranded, positive sense RNAvirus in the family Flaviviridae. HCV has a high rate of replication with approximately one trillion particles produced each day in an infected individual. Due to lack of proofreading by the HCV RNA polymerase, the HCV has an exceptionally high mutation rate, a factor that may help it elude the host's immune response. Hepatitis C virus is classified into six genotypes(1-6) with several subtypes within each genotype. The preponderance and distribution of HCV genotypes varies globally. Genotype is clinically important in determining potential response to interferon-based therapy and the required duration of such therapy. Genotypes 1 and 4 are less responsive to interferon-based treatment than are the other genotypes (2, 3, 5 and 6).
Core protein p19; HCV core antigen; HCV core protein; Hepatitis C Virus core protein; Hepatitis C Virus Core Antigen; Hepatitis C virus; HCV; Flaviviridae; Hepacivirus